Methylene Blue and Red Light Therapy for Neuroprotection and Wellbeing
Summary: Methylene Blue and Red Light Therapy for Neuroprotection and Wellbeing
Overview
Methylene blue (MB) and red light therapy enhance mitochondrial function and provide neuroprotection. Together, they synergistically improve cognitive and overall health.
Mechanism of Action
Methylene Blue
- Electron Donor: MB donates electrons in the mitochondrial electron transport chain (ETC), enhancing oxygen delivery and ATP production.
- Inhibition of Nitric Oxide Synthase: Reduces nitric oxide production, stabilizing blood pressure and improving blood flow.
Photon Donor: Near-infrared light penetrates tissues, stimulating cytochrome c oxidase (Complex IV), enhancing ATP synthesis and cellular respiration.
- Energy Levels: Improved mitochondrial function increases ATP production, enhancing physical stamina and reducing fatigue.
- Cognitive Function: Supports brain health, improving memory, focus, and mental clarity.
- Mood Regulation: MB acts as a mild MAOI, balancing neurotransmitters and alleviating depression and anxiety.
- Pain Management: Anti-inflammatory and analgesic effects support conditions like arthritis and migraines.
- Infection Control: MB’s antimicrobial properties help prevent infections and support immune resilience.
- Methylene Blue: 1–2 mg/kg body weight. Monitoring required above 7 mg/kg. IV dose ~50 mg weekly. Oral dose ~80 mg and titrated upward.
- Red Light Therapy: Applied transcranially in the 660–1064 nm red–NIR spectrum for optimal penetration.
Protection against Neurodegeneration
Gonzalez-Lima and Auchter (2015) showed MB + NIR light enhances mitochondrial respiration and protects neurons.
From Mitochondrial Function to Neuroprotection
Tucker et al. (2018) demonstrated MB supports mitochondrial repair and may assist in Alzheimer’s and Parkinson’s treatment.
Infrared Phototherapy
Henderson and Morries (2015) found that NIR light improves cell survival, memory, and glucose metabolism.
Neurological & Psychological Applications
Rojas & Gonzalez-Lima (2013) showed transcranial lasers enhance blood flow and ATP production in neurons.
References
- Gonzalez-Lima & Auchter, 2015 – Frontiers in Cellular Neuroscience
- Tucker et al., 2018 – Molecular Neurobiology
- Henderson & Morries, 2015 – Neuropsychiatric Disease and Treatment
- Rojas & Gonzalez-Lima, 2013 – Biochemical Pharmacology
- Wadsworth & Korthuis, 2012 – American Journal of Physiology
- Hamblin, 2017 – AIMS Biophysics
- Sahl et al., 2016 – Investigative Ophthalmology & Visual Science
- Bennett et al., 2016 – Cochrane Reviews
- Greco et al., 2001 – Journal of Bioenergetics
- Cassano et al., 2015 – Psychiatry Journal
